Ranju Baral

2.6k total citations
39 papers, 588 citations indexed

About

Ranju Baral is a scholar working on Epidemiology, Pediatrics, Perinatology and Child Health and General Health Professions. According to data from OpenAlex, Ranju Baral has authored 39 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 9 papers in Pediatrics, Perinatology and Child Health and 8 papers in General Health Professions. Recurrent topics in Ranju Baral's work include Respiratory viral infections research (15 papers), Pneumonia and Respiratory Infections (12 papers) and Global Maternal and Child Health (9 papers). Ranju Baral is often cited by papers focused on Respiratory viral infections research (15 papers), Pneumonia and Respiratory Infections (12 papers) and Global Maternal and Child Health (9 papers). Ranju Baral collaborates with scholars based in United States, United Kingdom and Kenya. Ranju Baral's co-authors include Clint Pecenka, Andrew Clark, Joseph L. Dieleman, Elizabeth K. Johnson, Frédéric Debellut, Katherine Leach‐Kemon, Casey M Graves, Annie Haakenstad, Christopher J L Murray and Tara Templin and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ranju Baral

37 papers receiving 574 citations

Peers

Ranju Baral
Muluneh Alene Ethiopia
Ranju Baral
Citations per year, relative to Ranju Baral Ranju Baral (= 1×) peers Muluneh Alene

Countries citing papers authored by Ranju Baral

Since Specialization
Citations

This map shows the geographic impact of Ranju Baral's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ranju Baral with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ranju Baral more than expected).

Fields of papers citing papers by Ranju Baral

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ranju Baral. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ranju Baral. The network helps show where Ranju Baral may publish in the future.

Co-authorship network of co-authors of Ranju Baral

This figure shows the co-authorship network connecting the top 25 collaborators of Ranju Baral. A scholar is included among the top collaborators of Ranju Baral based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ranju Baral. Ranju Baral is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mahmud, Sarwat, Ranju Baral, Clint Pecenka, et al.. (2024). Evaluation of the potential impact and cost-effectiveness of respiratory syncytial virus (RSV) prevention strategies for infants in Argentina. Vaccine. 42(23). 126234–126234. 5 indexed citations
2.
Jiao, Boshen, Ryoko Sato, Clint Pecenka, et al.. (2024). Association between achieving adequate antenatal care and health-seeking behaviors: A study of Demographic and Health Surveys in 47 low- and middle-income countries. PLoS Medicine. 21(7). e1004421–e1004421. 3 indexed citations
3.
Pecenka, Clint, Andrea Rodríguez, Carlos Rojas‐Roque, et al.. (2024). Assessing the long-term economic impact of wheezing episodes after severe RSV disease in children from Argentina: a cost of illness analysis. SHILAP Revista de lepidopterología. 2(1). e000975–e000975.
4.
Debellut, Frédéric, et al.. (2024). The cost of typhoid illness in low- and middle-income countries, a scoping review of the literature. PLoS ONE. 19(6). e0305692–e0305692. 5 indexed citations
5.
Nyiro, Joyce U., Bryan O. Nyawanda, Martin Mutunga, et al.. (2024). The cost of care for children hospitalized with respiratory syncytial virus (RSV) associated lower respiratory infection in Kenya. BMC Public Health. 24(1). 2410–2410. 3 indexed citations
6.
Baral, Ranju, Elkanah Otiang, John O. Odiyo, et al.. (2024). Cost of delivering childhood RSV prevention interventions to the health system in Kenya: a prospective analysis. BMJ Open. 14(11). e084207–e084207. 2 indexed citations
7.
Pecenka, Clint, Erin Sparrow, Daniel R. Feikin, et al.. (2024). Respiratory syncytial virus vaccination and immunoprophylaxis: realising the potential for protection of young children. The Lancet. 404(10458). 1157–1170. 20 indexed citations
9.
Nyawanda, Bryan O., Joyce U. Nyiro, Elisabeth Vodicka, et al.. (2023). Respiratory Syncytial Virus (RSV) Disease and Prevention Products: Knowledge, Attitudes, and Preferences of Kenyan Healthcare Workers in Two Counties in 2021. Vaccines. 11(6). 1055–1055. 4 indexed citations
10.
Baral, Ranju, Andrea G. Buchwald, James D. Campbell, et al.. (2023). Optimizing next-generation RSV prevention in Mali: A cost-effectiveness analysis of pediatric vaccination, maternal vaccination, and extended half-life monoclonal antibody immunoprophylaxis. SHILAP Revista de lepidopterología. 3(5). e0001432–e0001432. 7 indexed citations
11.
Wittenauer, Rachel, Clint Pecenka, & Ranju Baral. (2023). Cost of childhood RSV management and cost-effectiveness of RSV interventions: a systematic review from a low- and middle-income country perspective. BMC Medicine. 21(1). 121–121. 20 indexed citations
12.
Fitzpatrick, Meagan C., Ranju Baral, Amanda J. Driscoll, et al.. (2023). Report of the WHO technical consultation on the evaluation of respiratory syncytial virus prevention cost effectiveness in low- and middle-income countries, April 7–8, 2022. Vaccine. 41(48). 7047–7059. 11 indexed citations
14.
Debellut, Frédéric, Andrew Clark, Clint Pecenka, et al.. (2021). Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling study. The Lancet Global Health. 9(7). e942–e956. 16 indexed citations
15.
Driscoll, Amanda J., Ranju Baral, Andrea G. Buchwald, et al.. (2021). Cost-effectiveness of infant respiratory syncytial virus preventive interventions in Mali: A modeling study to inform policy and investment decisions. Vaccine. 39(35). 5037–5045. 14 indexed citations
16.
Baral, Ranju, Xiao Li, Lander Willem, et al.. (2020). The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two models. Vaccine. 38(33). 5139–5147. 16 indexed citations
17.
Debellut, Frédéric, Andrew Clark, Clint Pecenka, et al.. (2019). Re-evaluating the potential impact and cost-effectiveness of rotavirus vaccination in 73 Gavi countries: a modelling study. The Lancet Global Health. 7(12). e1664–e1674. 49 indexed citations
18.
Anderson, John, Karoun H. Bagamian, Farzana Muhib, et al.. (2019). Potential impact and cost-effectiveness of future ETEC and Shigella vaccines in 79 low- and lower middle-income countries. Vaccine X. 2. 100024–100024. 28 indexed citations
19.
20.
Zelman, Brittany, Ranju Baral, Farah N. Coutrier, et al.. (2017). EVALUATING THE COSTS AND COST-EFFECTIVENESS OF MICROSCOPY COMPARED TO LAMP USED DURING REACTIVE CASE DETECTION IN ACEH PROVINCE, INDONESIA. American Journal of Tropical Medicine and Hygiene. 95(5). 473–473.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026